SLP
Simulations PlusยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SLP Profile
Simulations Plus, Inc.
A leading provider in the biosimulation market that provides software and consulting services supporting drug discovery, development, research, and regulatory submissions
Healthcare Technology
07/17/1996
12/31/2007
NASDAQ Stock Exchange
212
08-31
Common stock
800 Park Offices Drive, Suite 401, Research Triangle Park, NC 27709
--
Simulations Plus, Inc., was incorporated in California on July 17, 1996. The company is a global leader and premier supplier in biopharmaceuticals, providing advanced software and consulting services to enhance drug discovery and development, clinical trial operations and commercialization. The Company supports its clients throughout the entire drug development lifecycle, from early detection to clinical development (" R&D "), including clinical operations, to product commercialization. The company serves clients as a strategic partner throughout the drug development lifecycle, providing solutions that integrate scientific software platforms, artificial intelligence-enhanced insights, and expert consulting.
